Disulfiram repurposing in the combined chemotherapy of Chagas disease-Reference-Cited by-同舟云学术

Disulfiram repurposing in the combined chemotherapy of Chagas disease

Published:2021-07 Issue:7 Volume:2 Page:e0110
ISSN:2691-3895
Container-title:Medicine: Case Reports and Study Protocols
language:en
Short-container-title:

Author:

Saraiva Roberto Magalhães,Portela Luciana Fernandes,Silveira Gabriel Parreiras Estolano da,Gomes Natalia Lins da Silva,Pinto Douglas Pereira,Silva Aline Campos de Azevedo da,Sangenis Luiz Henrique Conde,Carneiro Fernanda Martins,Almeida-Silva Juliana,Marinho Patricia Wink,Sperandio-Silva Gilberto Marcelo,Estrela Rita de Cássia Elias,Hasslocher-Moreno Alejandro Marcel,Mediano Mauro Felippe Felix,Moreira Otacilio C.,Britto Constança,Perez Sandra Aurora Chavez,Viçosa Alessandra Lifsitch,Suarez-Fontes Ana Márcia,Vannier-Santos Marcos André

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health

Reference44 articles.

1. 2nd Brazilian consensus on Chagas disease;Dias;Epidemiol Serv Saúde,2016

2. Chagas disease;Pérez-Molina;Lancet,2018

3. Toxic side effects of drugs used to treat Chagas’ disease (American Trypanosomiasis);Castro;Hum Exp Toxicol,2006

4. Adverse systemic reaction to benznidazole;Coronel;Rev Soc Bras Med Trop,2017

5. Safety of benznidazole use in the treatment of chronic Chagas’ disease;Hasslocher-Moreno;J Antimicrob Chemother,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities;Frontiers in Pharmacology;2023-07-27

2. The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance;Frontiers in Cellular and Infection Microbiology;2022-07-29

3. Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning;Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention;2022-07-13

4. New Therapeutics for Chagas Disease: Charting a Course to Drug Approval;Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention;2022-07-13

5. In Vitro Validation of Antiparasitic Activity of PLA-Nanoparticles of Sodium Diethyldithiocarbamate against Trypanosoma cruzi;Pharmaceutics;2022-02-24